The Current Ratio as of November 2024 (TTM) for Dynavax Technologies Corporation (DVAX) is 13.23

According to Dynavax Technologies Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 13.23. This represents a change of -6.23% compared to the average of 14.11 of the last 4 quarters.

Dynavax Technologies Corporation (DVAX) Historical Current Ratio (quarterly & annually)

How has DVAX Current Ratio performed in the past?

The mean historical Current Ratio of Dynavax Technologies Corporation over the last ten years is 5.76. The current 13.23 Current Ratio has changed 22.86% with respect to the historical average. Over the past ten years (40 quarters), DVAX's Current Ratio was at its highest in in the June 2023 quarter at 17.78. The Current Ratio was at its lowest in in the December 2021 quarter at 1.09.

Dynavax Technologies Corporation (DVAX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Dynavax Technologies Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dynavax Technologies Corporation (DVAX) Average Current Ratio

How has DVAX Current Ratio performed in the past?

The current Current Ratio of Dynavax Technologies Corporation (DVAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Dynavax Technologies Corporation (DVAX) Current Ratio vs. Peers

How is DVAX’s Current Ratio compared to its peers?

Dynavax Technologies Corporation’s Current Ratio is greater than Alkermes plc (3.45), greater than Neurocrine Biosciences, Inc. (4.37), greater than Intra-Cellular Therapies, Inc. (7.66), greater than Deciphera Pharmaceuticals, Inc. (4.19), greater than Aquestive Therapeutics, Inc. (6.37), greater than Amphastar Pharmaceuticals, Inc. (3.43), greater than Lantheus Holdings, Inc. (1.65), greater than ANI Pharmaceuticals, Inc. (2.74), greater than Ironwood Pharmaceuticals, Inc. (3.62), greater than Pacira BioSciences, Inc. (2.25), greater than Collegium Pharmaceutical, Inc. (0.97), greater than Eagle Pharmaceuticals, Inc. (1.70), greater than Emergent BioSolutions Inc. (2.88), greater than DURECT Corporation (0.71),

Build a custom stock screener for Dynavax Technologies Corporation (DVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dynavax Technologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dynavax Technologies Corporation (DVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dynavax Technologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.